Watchlist Price Alert

VYNE Therapeutics Inc. (VYNE)

NASDAQ: VYNE · Real-Time Price · USD

1.37

0.03 (2.24%)

At close: May 02, 2025, 3:59 PM

1.36

-0.73%

After-hours: May 02, 2025, 05:48 PM EDT

VYNE Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	501K	424K	477K	14.76M	20.99M	443K	10.64M	4.58M	674K
Cost of Revenue	4K	n/a	n/a	3.35M	1.39M	350K	n/a	n/a	n/a
Gross Profit	497K	424K	477K	11.41M	19.6M	93K	10.64M	4.58M	674K
Operating Income	-43.64M	-29.26M	-34.3M	-68.03M	-113.47M	-76.24M	-54.53M	-29.59M	-14.33M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	3.09M	517K	264K
Pretax Income	-39.8M	-27.87M	-33.93M	-73.78M	-255.83M	-73.7M	-51.45M	-29.08M	-14.07M
Net Income	-39.83M	-28.45M	-33.95M	-73.33M	-255.57M	-70.46M	-51.45M	-29.08M	-14.07M
Selling & General & Admin	13.19M	13.38M	16.39M	54.48M	89.54M	22.48M	12.19M	5.17M	3.75M
Research & Development	30.95M	16.31M	18.39M	24.96M	43.53M	53.76M	52.99M	29.01M	11.26M
Other Expenses	n/a	n/a	363K	-135K	1.11M	n/a	n/a	n/a	n/a
Operating Expenses	44.14M	29.68M	34.77M	79.44M	133.08M	76.24M	65.17M	34.17M	15.01M
Interest Expense	n/a	n/a	n/a	5.61M	4.39M	2.54M	3.09M	517K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	44.14M	29.68M	34.77M	82.79M	134.47M	76.24M	65.17M	34.17M	15.01M
Income Tax Expense	4K	n/a	13K	-448K	-258K	-3.24M	3.09M	-8K	n/a
Shares Outstanding (Basic)	42.59M	10.27M	3.19M	2.86M	1.8M	471.39K	300.95K	286.04K	160.27K
Shares Outstanding (Diluted)	42.59M	10.27M	3.19M	2.86M	1.8M	471.39K	300.95K	286.04K	160.27K
EPS (Basic)	-0.93	-2.77	-10.65	-25.65	-141.9	-149.48	-170.94	-101.65	-87.78
EPS (Diluted)	-0.93	-2.77	-10.65	-25.65	-141.9	-149.48	-170.94	-101.65	-87.78
EBITDA	-43.63M	-29.26M	-34.22M	-38.94M	-251.09M	-94.08M	-54.53M	-29.59M	-14.33M
EBIT	-43.64M	-29.26M	-34.3M	-39.05M	-251.44M	-94.43M	-54.53M	-29.59M	-14.33M
Depreciation & Amortization	4K	n/a	72K	109K	341K	350K	22K	8K	4K